Company: GRCE
Filing Date: 2025-07-28
Form Type: DEF 14A
Source: 0001140361-25-027456
Chunk: 27

Company: Grace Therapeutics, Inc.
Filing Date: 2025-07-28
Form: DEF 14A
Chunk 27
---
 to the Board must possess the following minimum characteristics:

| • | the highest level of personal and professional ethics, integrity and values; |

| • | demonstrated strong business judgement and professional achievement; |

| • | expertise that is useful to the Company and complementary to the background and experience of other Board members; |

| • | willingness to devote the required time to carrying out the duties and responsibilities of Board membership; |

| • | strong sense of professionalism; |

| • | willingness to represent the best interests of all stockholders and objectively appraise management performance; and |

| • | involvement only in activities or interests that do not conflict with the director’s responsibilities to the Company and its stockholders. |

In the case of incumbent directors whose terms of office are set to expire, we review such directors’ overall service to the Company during their term of office, including the number of meetings attended, level of participation, quality of performance and any transactions of such directors with the Company during their term of office. We may use various sources in order to identify the candidates for the Board, including its own contacts and the references of our other directors, officers, advisors and executive placement agencies. The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders and will evaluate director candidates in the same manner in which it evaluates candidates recommended by other sources, including the minimum criteria set forth above. Stockholder Nominations of Director Candidates at an Annual Meeting Stockholders who wish to nominate a candidate for election to our Board may do so by delivering a written notice to the Nominating and Corporate Governance Committee at the Company’s principal executive offices: Grace Therapeutics, Inc., 103 Carnegie Center, Suite 300, Princeton, New Jersey 08540, Attn: Secretary, not later

16

TABLE OF CONTENTS than the close of business on the 90 thday, nor earlier than 120 thday, prior to the first anniversary of the preceding year’s annual meeting of stockholders. However, in the event that the date of the annual meeting of stockholders is more than 30 days before or more than 70 days after such anniversary date, notice by the stockholder must be so delivered not earlier than the 120 thday prior to such annual meeting and not later than the close of business on the later of the 90 thday prior to such annual meeting or the 10 thday following the day on which public announcement of the date of such meeting is first made by the Company. Submissions must include, among other